An employee checks the production of chloroquine phosphate, resumed after a 15-year break, in a pharmaceutical company in Nantong city in east China’s Jiangsu province Thursday, Feb. 27, 2020. Chloroquine phosphate, an old drug for the treatment of malaria, has shown some efficacy and acceptable safety against COVID-19 associated pneumonia in trials, according to Chinese media.
Feature China | Barcroft Media | Getty Images
The Food and Drug Administration warned consumers Friday against taking chloroquine and hydroxychloroquine to treat Covid-19 outside a hospital or formal clinical trial after “serious” poisoning and deaths were reported.
This is a developing story. Please check back for updates.
This article was originally published by Cnbc.com. Read the original article here.